(Q43183398)

English

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions

scientific article published on 17 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions (English)

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

0 references

1 reference

based on heuristic

inferred from title

Susanne Perkhofer

1

object named as

Susanne Perkhofer

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Cornelia Lass-Florl

4

object named as

Cornelia Lass-Flörl

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

author name string

Daniel Jost

2

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Manfred P Dierich

3

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

language of work or name

0 references

publication date

17 March 2008

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

52

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

5

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

1873-1875

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Anidulafungin: a novel echinocandin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

The past, present and future of antimycotic combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Virulence factors of medically important fungi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

25 May 2018

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

15 August 2018

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

15 August 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

15 August 2018

Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346651

15 August 2018

Combination antifungal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal susceptibility testing inAspergillusspp. according to EUCAST methodology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01572-07

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43183398&oldid=1983021087"